192 related articles for article (PubMed ID: 28892473)
1. A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.
Chesnais CB; Awaca-Uvon NP; Bolay FK; Boussinesq M; Fischer PU; Gankpala L; Meite A; Missamou F; Pion SD; Weil GJ
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005703. PubMed ID: 28892473
[TBL] [Abstract][Full Text] [Related]
2. A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration.
Yahathugoda TC; Supali T; Rao RU; Djuardi Y; Stefani D; Pical F; Fischer PU; Lloyd MM; Premaratne PH; Weerasooriya MV; Weil GJ
Parasit Vectors; 2015 Jul; 8():369. PubMed ID: 26168919
[TBL] [Abstract][Full Text] [Related]
3. Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.
Yokoly FN; Zahouli JBZ; Méite A; Opoku M; Kouassi BL; de Souza DK; Bockarie M; Koudou BG
PLoS One; 2020; 15(4):e0231541. PubMed ID: 32282840
[TBL] [Abstract][Full Text] [Related]
4. Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon.
Wanji S; Esum ME; Njouendou AJ; Mbeng AA; Chounna Ndongmo PW; Abong RA; Fru J; Fombad FF; Nchanji GT; Ngongeh G; Ngandjui NV; Enyong PI; Storey H; Curtis KC; Fischer K; Fauver JR; Lew D; Goss CW; Fischer PU
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007192. PubMed ID: 30849120
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali.
Coulibaly YI; Coulibaly SY; Dolo H; Konate S; Diallo AA; Doumbia SS; Soumaoro L; Coulibaly ME; Dicko I; Sangare MB; Dembele B; Sangare M; Dembele M; Touré YT; Kelly-Hope L; Polman K; Kyelem D; Traore SF; Bockarie M; Klion AD; Nutman TB
Parasit Vectors; 2016 Dec; 9(1):628. PubMed ID: 27912789
[TBL] [Abstract][Full Text] [Related]
6. Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region.
Wanji S; Amvongo-Adjia N; Koudou B; Njouendou AJ; Chounna Ndongmo PW; Kengne-Ouafo JA; Datchoua-Poutcheu FR; Fovennso BA; Tayong DB; Fombad FF; Fischer PU; Enyong PI; Bockarie M
PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004184. PubMed ID: 26544042
[TBL] [Abstract][Full Text] [Related]
7. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.
Beng AA; Esum ME; Deribe K; Njouendou AJ; Ndongmo PWC; Abong RA; Fru J; Fombad FF; Nchanji GT; Amambo G; Gandjui NTV; Biholong B; Nko'Ayissi G; Mbia P; Akame J; Enyong PI; Reid SD; Tougoue JJ; Zhang Y; Wanji S
BMC Infect Dis; 2020 Apr; 20(1):284. PubMed ID: 32299374
[TBL] [Abstract][Full Text] [Related]
8. Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia.
Pion SD; Montavon C; Chesnais CB; Kamgno J; Wanji S; Klion AD; Nutman TB; Boussinesq M
Am J Trop Med Hyg; 2016 Dec; 95(6):1417-1423. PubMed ID: 27729568
[TBL] [Abstract][Full Text] [Related]
9. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
[TBL] [Abstract][Full Text] [Related]
10. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
11. Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures.
Gounoue-Kamkumo R; Nana-Djeunga HC; Bopda J; Akame J; Tarini A; Kamgno J
BMC Infect Dis; 2015 Dec; 15():579. PubMed ID: 26700472
[TBL] [Abstract][Full Text] [Related]
12. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic filariasis mapping by immunochromatographic test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone.
Koroma JB; Bangura MM; Hodges MH; Bah MS; Zhang Y; Bockarie MJ
Parasit Vectors; 2012 Jan; 5():10. PubMed ID: 22236419
[TBL] [Abstract][Full Text] [Related]
14. Rapid assessment for lymphatic filariasis in central Nigeria: a comparison of the immunochromatographic card test and hydrocele rates in an area of high endemicity.
Eigege A; Richards FO; Blaney DD; Miri ES; Gontor I; Ogah G; Umaru J; Jinadu MY; Mathai W; Amadiegwu S; Hopkins DR
Am J Trop Med Hyg; 2003 Jun; 68(6):643-6. PubMed ID: 12887020
[TBL] [Abstract][Full Text] [Related]
15. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood.
Weil GJ; Curtis KC; Fakoli L; Fischer K; Gankpala L; Lammie PJ; Majewski AC; Pelletreau S; Won KY; Bolay FK; Fischer PU
Am J Trop Med Hyg; 2013 Jul; 89(1):11-15. PubMed ID: 23690552
[TBL] [Abstract][Full Text] [Related]
16. Assessing drivers of the IgG4 antibody reactivity to recombinant antigen Bm14 in Wuchereria bancrofti endemic populations in East Africa.
Damgaard J; Meyrowitsch DW; Rwegoshora RT; Magesa SM; Mukoko DA; Simonsen PE
Acta Trop; 2016 Sep; 161():26-32. PubMed ID: 27172877
[TBL] [Abstract][Full Text] [Related]
17. Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer.
Chesnais CB; Vlaminck J; Kunyu-Shako B; Pion SD; Awaca-Uvon NP; Weil GJ; Mumba D; Boussinesq M
Am J Trop Med Hyg; 2016 Jun; 94(6):1324-1329. PubMed ID: 27114288
[TBL] [Abstract][Full Text] [Related]
18. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
[TBL] [Abstract][Full Text] [Related]
19. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.
Subramanian S; Jambulingam P; Krishnamoorthy K; Sivagnaname N; Sadanandane C; Vasuki V; Palaniswamy C; Vijayakumar B; Srividya A; Raju HKK
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007862. PubMed ID: 31978060
[TBL] [Abstract][Full Text] [Related]
20. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
